Siloam International Hospitals Tbk PT Financials

Market Capitalization €1.75 Billion as of Jan. 1, 2026

Valuations Metrics as of Jan. 3, 2026

Trailing PE	13.10
Forward PE
Price to Sales TTM	€2.82
Price to Book MRQ	€0.00
Enterprise to Revenue	2.87
Enterprise to EBITDA	13.67

Financial Reports as of Jun. 30, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-06-30
Profit Margin	8.22%
Operating Margin	11.61%
Return on Assets TTM	7.76%
Return on Equity TTM	11.97%

Income Statement

Revenue TTM	€622,671,165
Revenue per Share TTM	€940.32
Quarterly Revenue Growth	6.90%
Gross Profit TTM	€247,997,666
EBITDA	€127,302,249
Net Income to Common TTM	€46,016,067
Diluted EPS TTM	€69.19
Quarterly Earnings Growth YoY	-5.00%

Balance Sheet

Total Cash MRQ	€30,308,818
Total Cash per Share MRQ	€
Total Debt MRQ	€
Total Debt to Equity MRQ	17.61
Current Ratio MRQ	0.75
Book Value per Share MRQ	€720.32

Cash Flow

Operating Cash Flow TTM	€None
Levered Free Cash Flow TTM	€26,556,776

2LS Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding	12,988,513,353
Float Shares	1,269,528,491
Avg 10 Volume	1,658
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	93.24%
% Held by Institutions	1.02%

Stock Price Summary

Beta	0.24
Fifty Two Week Low	€0.09
Fifty Two Week High	€0.18
Fifty Two Week Change	-42.06%
Day 50 MA	€0.12
Day 200 MA	€0.11

Dividends and Splits

Forward Annual Dividend Rate	€0.00
Forward Annual Dividend Yield	3.24%
Trailing Annual Dividend Rate	€0.00
Trailing Annual Dividend Yield	0.81%
Payout Ratio	0.00%
Dividend Date
Ex Dividend Date	2024-06-10
Last Split Factor
Last Split Date	2022-04-08